Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
Reddy, Tejaswini P., Choi, Dong S., Anselme, Ann C., Qian, Wei, Chen, Wen, Lantto, Johan, Horak, Ivan D., Kragh, Michael, Chang, Jenny C., Rosato, Roberto R.Volume:
22
Journal:
Breast Cancer Research
DOI:
10.1186/s13058-020-01280-z
Date:
December, 2020
File:
PDF, 1.95 MB
2020